CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishAbstract Evidence suggests that the JAK2 V617F mutationis associated with an increased risk of first thrombosisin patients with essential thrombocythemia (ET). Whetherthis mutation is also a risk factor for recurrent thrombosis iscurrently unknown. To investigate the impact of the JAK2V617F mutation on the risk of recurrent thrombosis inpatients with ET, we carried out a multicentre retrospectivecohort study. We recruited 143 patients with previousarterial (64.4%) or venous major thrombosis (34.8%) orboth (0.8%); 98 of them (68.5%) carried the mutation
| Titolo: | Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation |
| Autori interni: | |
| Data di pubblicazione: | 2010 |
| Rivista: | |
| Citazione: | Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V7ì617F mutation / DE STEFANO, V; Za, T; Rossi, E; Vannucchi, Am; Ruggeri, M; Elli, E; Micò, C; Tieghi, A; Cacciola, Rr; Santoro, C; Vianelli, N; Guglielmelli, P; Pieri, L; Scognamiglio, F; Cacciola, Emma; Rodeghiero, F; Pogliani, Em; Finazzi, G; Gugliotta, L; Leone, G; Barbui, T; GIMEMA CHRONIC, Myeloproliferative; NEOPLASMS WORKING, Party. - In: ANNALS OF HEMATOLOGY. - ISSN 0939-5555. - 89(2)(2010), pp. 141-146. |
| Handle: | http://hdl.handle.net/20.500.11769/53083 |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
http://hdl.handle.net/20.500.11769/53083
Copyright © 2019